Both in Biotechnology
Cognition Therapeutics vs Kalaris Therapeutics
Over the past year CGTX returned −59.2% and KLRS returned −55.4%; their daily moves had a correlation of 0.12.
CGTX −59.2% KLRS −55.4%Growth of $1, one year, split-adjusted
| Metric | CGTX | KLRS |
|---|---|---|
| Price | $0.6405 | $2.10 |
| Market cap | $60.9M | $50.0M |
| Today | −6.26% | +3.96% |
| 1 month | −31.6% | −18.0% |
| 6 months | −44.8% | −59.2% |
| Year to date | −52.6% | −75.1% |
| 1 year | −59.2% | −55.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.0M | $93.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.8% | 56.9% |
| Short % of float | 8.3% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).